Used in pharmaceutical synthesis as an intermediate for kinase inhibitors, particularly in the development of targeted cancer therapies. Its structure supports the formation of bioactive molecules with high selectivity for protein kinases involved in tumor growth. Commonly employed in medicinal chemistry for constructing peptidomimetic compounds due to the protected amine group, enabling stepwise assembly of complex drug candidates. Also utilized in solid-phase synthesis and combinatorial chemistry for generating compound libraries in drug discovery.